Difficulty in establishing the impact of drugs on quality of life in cognitively impaired patients- Example of attempting to derive utility in patients treated with rifaximin-α for the reduction of recurrence of episodes of hepatic encephal ...
Abstract
Authors
E. Berni P. Conway K. Nanuwa C.J. Currie